Parenteral Drugs (India) reports consolidated net loss of Rs 22.14 crore in the September 2016 quarter
Sales decline 21.69% to Rs 62.63 crore
Net Loss of Parenteral Drugs (India) reported to Rs 22.14 crore in the quarter ended September 2016 as against net loss of Rs 14.54 crore during the previous quarter ended September 2015. Sales declined 21.69% to Rs 62.63 crore in the quarter ended September 2016 as against Rs 79.98 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales62.6379.98 -22 OPM %2.087.70 -PBDT-20.10-7.26 -177 PBT-26.16-14.02 -87 NP-22.14-14.54 -52Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 16 2016 | 5:48 PM IST